Resource Centers
- UK NICE Recommends Erlotinib Use in NSCLC After Price Reduction
- Early Teriparatide Response May Hinge on Prior Bisphosphonate Therapy
- Febuxostat Outperforms Allopurinol in Lowering Urate Levels
- Recalls & Warnings FDA Investigates Genetic Link to Phenytoin Skin Reactions
- FDA Safety Changes: Heparin Sodium Injection, Photofrin, Noroxin
- Lack of Exercise, Other Bad Behaviors Explain Link Between Depression and CVD, Study Suggests
Internal Medicine Journals
- Incremental Prognostic Value of the Exercise Electrocardiogram in the Initial Assessment of Patients With Suspected Angina: Cohort Study
- Helicobacter pylori: Friend and Foe?
- Prevalence and Correlates of Silent Cerebral Infarcts in the Framingham Offspring Study. Ranked "Changes Clinical Practice" From F1000.
Medscape Community Resources
- Should a Patient Exposed to Shingles Receive the Zoster Vaccine?
- New ASH Diabetes Guidelines, Plus Data on Hypertension Prevalence, Ineffective Drugs, Harmful Drugs, and the Polypill
- Colon Cancer Screening: An Age to Start and an Age to Stop?
- Adverse Events of LTBI Therapy & Postthrombotic Syndrome After Acute DVT
POLL
New regimens for treating advanced colorectal cancer have been reported as increasingly expensive. This poses an ethical question about whether prolonging a patient's life for a short time is worth the high cost when a cure is not possible. Do you approve or disapprove of such expensive treatment in advanced cancer when a cure is not possible?
Expert Video Blogs
Internal Medicine CME
- Managing Hypertension in Cardiology Practice According to Risk Profile
- Challenges in Recognizing Chronic Constipation and IBS-C: A Clinician Dialogue
- Healthier Life Steps: A Clinician-Patient Guide From the AMA
- A 60-Year-Old Woman With Progressive Neuropsychiatric Symptoms and Myoclonic Jerks
- Advances in Glucagon-like Peptides for the Treatment of Type 2 Diabetes -- Volume 2
Latest from SHM at
Medscape.com/shm
Medscape.com/shm
Advisory Board
- Melissa Clarke, MD
- David C. Dale, MD, FACP
- James J. Foody, MD, FACP
- R. Brian Haynes, MD, PhD, MACP
- Daniel Z. Sands, MD, MPH
- Mark E. Williams, MD
Editorial Director
